Sanofi (SNY) Net Cash Flow (2019 - 2026)
Sanofi's Net Cash Flow history spans 9 years, with the latest figure at -$2.5 billion for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 425.76% to -$2.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $5.9 billion, a 48.51% increase, with the full-year FY2025 number at $167.6 million, up 114.4% from a year prior.
- Net Cash Flow hit -$2.5 billion in Q1 2026 for Sanofi, down from -$1.2 billion in the prior quarter.
- Over the last five years, Net Cash Flow for SNY hit a ceiling of $12.0 billion in Q4 2023 and a floor of -$4.5 billion in Q2 2024.
- Historically, Net Cash Flow has averaged $3.1 billion across 5 years, with a median of $2.0 billion in 2024.
- Biggest five-year swings in Net Cash Flow: tumbled 605.0% in 2024 and later skyrocketed 278.08% in 2025.
- Tracing SNY's Net Cash Flow over 5 years: stood at $11.2 billion in 2022, then grew by 6.9% to $12.0 billion in 2023, then crashed by 103.03% to -$362.3 million in 2024, then plummeted by 221.33% to -$1.2 billion in 2025, then plummeted by 113.42% to -$2.5 billion in 2026.
- Business Quant data shows Net Cash Flow for SNY at -$2.5 billion in Q1 2026, -$1.2 billion in Q4 2025, and $1.6 billion in Q3 2025.